SMITH JASON DREW (General Counsel) sold 18.5% of their position (7.38K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $82.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Ordinary Shares
Shares
+2.50K
Price / share
—
Trade value
—
% of position
Ordinary Shares
Shares
−1.26K
Price / share
$11.14
Trade value
$14.01K
% of position
Ordinary Shares
Shares
+6.67K
Price / share
—
Trade value
—
% of position
Ordinary Shares
Shares
−3.35K
Price / share
$11.14
Trade value
$37.36K
% of position
Ordinary Shares
Shares
+5.50K
Price / share
—
Trade value
—
% of position
Ordinary Shares
Shares
−2.77K
Price / share
$11.14
Trade value
$30.82K
% of position
Net shares
+7.29K
Net value
-$82.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/31/2025 | M · Option Exercise | +2.50K | — | — | 9.9% | 25.23K | 27.73K |
| Ordinary Shares Direct | 1/31/2025 | S · Sale | −1.26K | $11.14 | $14.01K | 4.5% | 27.73K | 26.47K |
| Ordinary Shares Direct | 1/31/2025 | M · Option Exercise | +6.67K | — | — | 25.2% | 26.47K | 33.13K |
| Ordinary Shares Direct | 1/31/2025 | S · Sale | −3.35K | $11.14 | $37.36K | 10.1% | 33.13K | 29.78K |
| Ordinary Shares Direct | 1/31/2025 | M · Option Exercise | +5.50K | — | — | 18.5% | 29.78K | 35.28K |
| Ordinary Shares Direct | 1/31/2025 | S · Sale | −2.77K | $11.14 | $30.82K | 7.8% | 35.28K | 32.51K |
| Total | +7.29K | -$82.20K | ||||||
Restricted Stock Units
Ordinary Shares
2.50K shares
Shares
−2.50K
Strike price
Held after
0.00
Exercisable
—
Restricted Stock Units
Ordinary Shares
6.67K shares
Shares
−6.67K
Strike price
Held after
6.67K
Exercisable
—
Restricted Stock Units
Ordinary Shares
5.50K shares
Shares
−5.50K
Strike price
Held after
11K
Exercisable
—
Restricted Stock Units
Ordinary Shares
10K shares
Shares
+10K
Strike price
Held after
10K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares2.50K shares | 1/31/2025 | M · Option Exercise | −2.50K | — | 0.00 | |
| Restricted Stock Units Direct | Ordinary Shares6.67K shares | 1/31/2025 | M · Option Exercise | −6.67K | — | 6.67K | |
| Restricted Stock Units Direct | Ordinary Shares5.50K shares | 1/31/2025 | M · Option Exercise | −5.50K | — | 11K | |
| Restricted Stock Units Direct | Ordinary Shares10K shares | 1/31/2025 | A · Award | +10K | — | 10K |